{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:44:01Z","timestamp":1790923441546,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(No. 82173928)"],"award-info":[{"award-number":["(No. 82173928)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sub-project of National Key R&D Program of China","award":["(2019YFC1712305)"],"award-info":[{"award-number":["(2019YFC1712305)"]}]},{"DOI":"10.13039\/100012551","name":"Applied Basic Research Program of Sichuan Province","doi-asserted-by":"publisher","award":["(No. 2020YJ0375)"],"award-info":[{"award-number":["(No. 2020YJ0375)"]}],"id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research Foundation of Sichuan Academy of Chinese Medicine Sciences","award":["(No. 2020JDKY0013)"],"award-info":[{"award-number":["(No. 2020JDKY0013)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77021-5","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T05:37:35Z","timestamp":1732945055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Costunolide and dehydrocostus lactone alleviate ulcerative colitis via regulating TLR4, NF-\u03baB and PI3K expression"],"prefix":"10.1038","volume":"14","author":[{"given":"Songting","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Chu Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"key":"77021_CR1","doi-asserted-by":"publisher","unstructured":"Torres, J., Billioud, V., Sachar, D. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative Colitis as A Progr\u00a0essive Disease: The Forgotten Evidence. Inflamm. Bowel Dis. 18(7), 1356-1363.https:\/\/doi.org\/10.1002\/ibd.22839 (2012).","DOI":"10.1002\/ibd.22839"},{"key":"77021_CR2","doi-asserted-by":"publisher","unstructured":"Li, Q. et al. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner. Pharmacol. Rev. 170, 105694. https:\/\/doi.org\/10.1016\/j.phrs.2021.105694 (2021).","DOI":"10.1016\/j.phrs.2021.105694"},{"key":"77021_CR3","doi-asserted-by":"publisher","unstructured":"Danese, S. & Fiocchi, C. Ulcerative Colitis. New Engl. J. Med. 365(18), 1713-1725 https:\/\/doi.org\/10.1056\/NEJMra1102942 (2011).","DOI":"10.1056\/NEJMra1102942"},{"key":"77021_CR4","doi-asserted-by":"publisher","unstructured":"Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative colitis. Lancet 389(10080), 1756-1770https:\/\/doi.org\/10.1016\/s0140-6736(16)32126-2 (2017).","DOI":"10.1016\/s0140-6736(16)32126-2"},{"key":"77021_CR5","doi-asserted-by":"publisher","unstructured":"Ord\u00e1s, I., Eckmann, L., Talamini, M., Baumgart, D. C. & Sandborn, W. J. Ulcerative colitis. Lancet 380 (9853), 1606-1619 https:\/\/doi.org\/10.1016\/s0140-6736(12)60150-0(2012).","DOI":"10.1016\/s0140-6736(12)60150-0"},{"key":"77021_CR6","doi-asserted-by":"crossref","unstructured":"Du, L. & Ha, C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol. Clin. North Am. 49(4), 643-654 10.1016\/j.gtc.2020.07.005 (2020).","DOI":"10.1016\/j.gtc.2020.07.005"},{"key":"77021_CR7","doi-asserted-by":"publisher","unstructured":"Wei, S. C. et al. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev. Gastroenterol. Hepatol. 15(3), 275-289 https:\/\/doi.org\/10.1080\/17474124.2021.1840976 (2021).","DOI":"10.1080\/17474124.2021.1840976"},{"key":"77021_CR8","doi-asserted-by":"publisher","unstructured":"Bertani, L. et al. Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Dig. Dis. Sci. 65(8), 2397-2402https:\/\/doi.org\/10.1007\/s10620-019-05959-y\u00a0(2020).","DOI":"10.1007\/s10620-019-05959-y"},{"key":"77021_CR9","doi-asserted-by":"publisher","unstructured":"Gu, P. et al. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int. Immunopharmacol. 50, 152 160https:\/\/doi.org\/10.1016\/j.intimp.2017.06.022 (2017).","DOI":"10.1016\/j.intimp.2017.06.022"},{"key":"77021_CR10","doi-asserted-by":"publisher","unstructured":"Wu, N., Lee, Y. C., Shah, N. & Harrison, D. J. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study. Clin. Ther. 36(8), 1231-1241, 1241.e1231-1233 https:\/\/doi.org\/10.1016\/j.clinthera.2014.06.014 (2014).","DOI":"10.1016\/j.clinthera.2014.06.014"},{"key":"77021_CR11","unstructured":"Shen, H. & Liu, Z. Chapter Twenty-Four Review of Drug Development for Ulcerative Colitis in Ulcerative colitis - the past, present and future of Chinese and Western medicine (ed. Shen, H.) 281-304 (Southeast University Press, 2009)."},{"key":"77021_CR12","doi-asserted-by":"publisher","unstructured":"Liu, H., Ma, L., Tang, F., Zhang, Y. & Yang, J. Protective effect of Radix Aucklandiae against ulcerative colitis in rats. World Chin. J. Dig. 24(33), 4467-4473 https:\/\/doi.org\/10.11569\/wcjd.v24.i33.4467 (2016).","DOI":"10.11569\/wcjd.v24.i33.4467"},{"key":"77021_CR13","unstructured":"Liu, H. Biomedicine and High-performance Medical Devices in New Technologies and New Models (ed. Liu, H.) 245-247 (ShangDong science technology Press, 2018)."},{"key":"77021_CR14","unstructured":"Li, D. & Gao, J. Chapter Six Receptor-based drug design in Basis of computer-aided drug design (eds. Li, D. & Gao, J.) 129 (Northwest agriculture and forestry university Press, 2018)."},{"key":"77021_CR15","doi-asserted-by":"publisher","unstructured":"Fan, J. Y., Fu, A. L. & Zhang, L. Progress in molecular docking. Quant. Biol. 7(2), 83-89 https:\/\/doi.org\/10.1007\/s40484-019-0172-y (2019).","DOI":"10.1007\/s40484-019-0172-y"},{"key":"77021_CR16","doi-asserted-by":"publisher","unstructured":"Marchal Bressenot, A. Which evidence for a treat to target strategy in ulcerative colitis? Best Pract. Res., Clin. Gastroenterol. 32-33, 3-8 https:\/\/doi.org\/10.1016\/j.bpg.2018.05.001 (2018).","DOI":"10.1016\/j.bpg.2018.05.001"},{"key":"77021_CR17","doi-asserted-by":"crossref","unstructured":"Chateau, T. et al. Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure. Am. J. Gastroenterol. 115(2), 179-189 10.14309\/ajg.0000000000000437 (2020).","DOI":"10.14309\/ajg.0000000000000437"},{"key":"77021_CR18","doi-asserted-by":"publisher","unstructured":"Schofield, J. B. & Haboubi, N. Histopathological Mimics of Inflammatory Bowel Disease. Inflamm. Bo\u00a0wel Dis. 26(7), 994-1009 https:\/\/doi.org\/10.1093\/ibd\/izz232 (2020).","DOI":"10.1093\/ibd\/izz232"},{"key":"77021_CR19","doi-asserted-by":"crossref","unstructured":"Ligumsky, M. et al. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology 81(3), 444-449(1981).","DOI":"10.1016\/0016-5085(81)90594-1"},{"key":"77021_CR20","doi-asserted-by":"crossref","unstructured":"Sharon, P., Ligumsky, M., Rachmilewitz, D. & Zor, U. Role of prostaglandins in ulcerative colitis. Gastr oenterology 75(4), 638-640 (1978).","DOI":"10.1016\/S0016-5085(19)31672-5"},{"key":"77021_CR21","doi-asserted-by":"publisher","unstructured":"Kawahito, Y. et al. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colit is. Gut 37(4), 544-551 https:\/\/doi.org\/10.1136\/gut.37.4.544 (1995).","DOI":"10.1136\/gut.37.4.544"},{"key":"77021_CR22","doi-asserted-by":"publisher","unstructured":"Miao, Z. et al. Using serum peptidomics to discovery the diagnostic marker for different stage of ulc erative colitis. J. Pharm. Biomed. Anal. 193, 113725 https:\/\/doi.org\/10.1016\/j.jpba.2020.113725 (2021).","DOI":"10.1016\/j.jpba.2020.113725"},{"key":"77021_CR23","doi-asserted-by":"publisher","unstructured":"Li, H. et al. The Combination of Aquilaria sinensis (Lour.) Gilg and Aucklandia costus Falc. Volatile Oi ls Exerts Antidepressant Effects in a CUMS-Induced Rat Model by Regulating the HPA Axis and Levelsof Neurotransmitters. Front. Pharmacol. 11, 614413https:\/\/doi.org\/10.3389\/fphar.2020.614413 (2020).","DOI":"10.3389\/fphar.2020.614413"},{"key":"77021_CR24","unstructured":"Chen, F., Shaw, P. C. & Wang, J. Dehydrocostus lactone as Cyclooxygenase-2 specific inhibitor. Cancer Res. 64(Suppl 7), S230 (2004)."},{"key":"77021_CR25","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer. Oxid. Med. Cell. Longevity 2016, 9875298 https:\/\/doi.org\/10.1155\/2016\/9875298 (2016).","DOI":"10.1155\/2016\/9875298"},{"key":"77021_CR26","doi-asserted-by":"crossref","unstructured":"Canbakan, B., Atay, K., Koroglu, E., Tuncer, M. & Senturk, H. P389. The value of oxidative stress par ameters to predict histological severity in ulcerative colitis. J. Crohns Colitis 10(Suppl 1), S294 (2016).","DOI":"10.1093\/ecco-jcc\/jjw019.508"},{"key":"77021_CR27","doi-asserted-by":"publisher","unstructured":"Jena, G., Trivedi, P. P. & Sandala, B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radical Res. 46(11), 1339-1345 https:\/\/doi.org\/10.3109\/10715762.2012.717692 (2012).","DOI":"10.3109\/10715762.2012.717692"},{"key":"77021_CR28","doi-asserted-by":"publisher","unstructured":"Elmaksoud, H. A. A., Motawea, M. H., Desoky, A. A., Elharrif, M. G. & Ibrahimi, A. Hydroxytyrosol al leviate intestinal inflammation, oxidative stress and apoptosis resulted in ulcerative colitis. Biomed. Pharmacother. 142, 112073 https:\/\/doi.org\/10.1016\/j.biopha.2021.112073 (2021).","DOI":"10.1016\/j.biopha.2021.112073"},{"key":"77021_CR29","doi-asserted-by":"publisher","unstructured":"Cheong, C. U. et al. Protective Effects of Costunolide against Hydrogen Peroxide-Induced Injury in PC 12 Cells. Molecules 21(7), 898 https:\/\/doi.org\/10.3390\/molecules21070898 (2016).","DOI":"10.3390\/molecules21070898"},{"key":"77021_CR30","doi-asserted-by":"publisher","unstructured":"Eliza, J., Daisy, P. & Ignacimuthu, S. Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm. Chem. Biol. Interact. 188(3), 467-472 https:\/\/doi.org\/10.1016\/j.cbi.2010.08.002 (2010).","DOI":"10.1016\/j.cbi.2010.08.002"},{"key":"77021_CR31","doi-asserted-by":"publisher","unstructured":"Zhang, X., Chu, C. & Huang, Y. Inhibition of thioredoxin-interacting protein may enhance the therape utic effect of dehydrocostus lactone in cardiomyocytes under doxorubicin stimulation via the inhibition of the inflammatory response. Exp. Ther. Med. 23(3), 226https:\/\/doi.org\/10.3892\/etm.2022.11150 (2022).","DOI":"10.3892\/etm.2022.11150"},{"key":"77021_CR32","doi-asserted-by":"publisher","unstructured":"Sahu, K. K., Minz, S., Kaurav, M. & Pandey, R. S. Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis. Artif. Cells, Nanomed., Biotechnol. 44(2), 642-653 https:\/\/doi.org\/10.3109\/21691401.2014.975239 (2016).","DOI":"10.3109\/21691401.2014.975239"},{"key":"77021_CR33","unstructured":"Guo, Y., Yin, F., Guo, J. & Zhang, X. Progress in treatment of ulcerative colitis complicated with cyto megalovirus infection. Int. J. Virol. 27(3), 262-264 (2020)."},{"key":"77021_CR34","doi-asserted-by":"publisher","unstructured":"Huang, X. L. et al. PI3K\/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. In flamm Res. 60(8), 727-734 https:\/\/doi.org\/10.1007\/s00011-011-0325-6 (2011).","DOI":"10.1007\/s00011-011-0325-6"},{"key":"77021_CR35","doi-asserted-by":"crossref","unstructured":"Cai, H., Li, L., Jiang, J., Zhao, C. & Yang, C. Costunolide enhances sensitivity of K562\/ADR chronic m yeloid leukemia cells to doxorubicin through PI3K\/Akt pathway. Phytother. Res. 33(6), 1683-1688 10.1002\/ptr.6355 (2019).","DOI":"10.1002\/ptr.6355"},{"key":"77021_CR36","doi-asserted-by":"crossref","unstructured":"Li, W., Ma, Y. B., Mao, Y. Q. & Lin, T. Dehydrocostus lactone suppresses cell growth and induces ap optosis in recombinant human papilloma virus\u201118 HaCaT cells via the PI3K\/Akt signaling pathway. Mo\u00a0l. Med. Rep. 17(6), 7925-7930 10.3892\/mmr.2018.8805 (2018).","DOI":"10.3892\/mmr.2018.8805"},{"key":"77021_CR37","doi-asserted-by":"publisher","unstructured":"Xu, C. & Dong, W. Role of hypoxia-inducible factor-1\u03b1 in pathogenesis and disease evaluation of ulce rative colitis. Exp. Ther. Med. 11(4), 1330-1334 https:\/\/doi.org\/10.3892\/etm.2016.3030 (2016).","DOI":"10.3892\/etm.2016.3030"},{"key":"77021_CR38","doi-asserted-by":"crossref","unstructured":"Lv, Q. et al. Costunolide ameliorates colitis via specific inhibition of HIF1\u03b1\/glycolysis-mediated Th17 differentiation. Int. Immunopharmacol. 97, 107688 10.1016\/j.intimp.2021.107688 (2021).","DOI":"10.1016\/j.intimp.2021.107688"},{"key":"77021_CR39","doi-asserted-by":"crossref","unstructured":"Sheng, W. et al. Dehydrocostus Lactone Enhances Chemotherapeutic Potential of Doxorubicin in Lung Cancer by Inducing Cell Death and Limiting Metastasis. Med. Sci. Monit. 24, 7850-7861 10.12659\/msm.911410 (2018).","DOI":"10.12659\/MSM.911410"},{"key":"77021_CR40","doi-asserted-by":"publisher","unstructured":"Mohamed, M. E., Elsayed, S. A., Madkor, H. R., Eldien, H. M. S. & Mohafez, O. M. Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-\u03baB and PPAR-\u03b3 pathways. Intest. Res. 19 (2), 194-205 https:\/\/doi.org\/10.5217\/ir.2020.00021 (2021).","DOI":"10.5217\/ir.2020.00021"},{"key":"77021_CR41","doi-asserted-by":"publisher","unstructured":"Mao, J. et al. Costunolide protects against alcohol-induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro. Phytother. Res. 36(3), 1268-1283 https:\/\/doi.org\/10.1002\/ptr.7383 (2022).","DOI":"10.1002\/ptr.7383"},{"key":"77021_CR42","doi-asserted-by":"publisher","unstructured":"Zhou, Q. et al. The Possible Anti-Inflammatory Effect of Dehydrocostus Lactone on DSS-Induced Colitis in Mice. Evid. Based Complement. Alternat. Med. 2020, 5659738 https:\/\/doi.org\/10.1155\/2020\/5659738 (2020).","DOI":"10.1155\/2020\/5659738"},{"key":"77021_CR43","unstructured":"Chinese Pharmacopoeia Commission. Monographs Part I Crude drugs and prepared slices of traditional Chinese medicines in Pharmacopoeia of the People's Republic of China 2020 edition (volume I) (eds. Yu, H. et al.) 65-66 (China Medical Science Press, 2020)."},{"key":"77021_CR44","doi-asserted-by":"publisher","unstructured":"Li, X., Wang, L., Ma, Y. & Huang, P. Study on the Processing Technology of Aucklandia lappa Decne. Strait Pharmaceutical Journal 33(10), 26-28 https:\/\/doi.org\/10.3969\/j.issn.1006-3765.2021.10.009 (2021).","DOI":"10.3969\/j.issn.1006-3765.2021.10.009"},{"key":"77021_CR45","unstructured":"Huang, X. & Sun, R. Chapter Three Pharmacological experimental design in Experimental methodology of pharmacology (eds. Wei, W., Wu, X. & Li, Y.) 71 (People\u2019s Medical Publishing House, 2010)"},{"key":"77021_CR46","doi-asserted-by":"publisher","unstructured":"Eliza, J., Daisy, P. & Ignacimuthu, S. Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm. Chem. Biol. Interact. 188(3), 467-472https:\/\/doi.org\/10.1016\/j.cbi.2010.08.002 (2010).","DOI":"10.1016\/j.cbi.2010.08.002"},{"key":"77021_CR47","doi-asserted-by":"publisher","unstructured":"Zhang, R. et al. Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K\/Akt\/Bad and ERS signalling pathway in human laryngeal carcinoma. J. Cell. Mol. Med. 24(11), 6028-6042 https:\/\/doi.org\/10.1111\/jcmm.15131 (2020).","DOI":"10.1111\/jcmm.15131"},{"key":"77021_CR48","doi-asserted-by":"publisher","unstructured":"Peng, Y. et al. Dehydrocostus lactone inhibits the proliferation of esophageal cancer cells in vivo and in vitro through ROS-mediated apoptosis and autophagy. Food Chem. Toxicol. 170, 113453 https:\/\/doi.org\/10.1016\/j.fct.2022.113453 (2022).","DOI":"10.1016\/j.fct.2022.113453"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77021-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T06:03:30Z","timestamp":1732946610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77021-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments follow the rules of Chengdu University of Traditional Chinese medicine on the management and use of experimental animals. The license number for experimental animal use is SYXK (Chuan) 2020\u2009\u2212\u2009124. This study was approved by the Animal Ethics Committee of Chengdu University of Traditional Chinese Medicine. The authors complied with the ARRIVE guidelines and AVMA guidelines for the euthanasia of animals in the experiment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"29777"}}